JP2002526499A5 - - Google Patents

Download PDF

Info

Publication number
JP2002526499A5
JP2002526499A5 JP2000574109A JP2000574109A JP2002526499A5 JP 2002526499 A5 JP2002526499 A5 JP 2002526499A5 JP 2000574109 A JP2000574109 A JP 2000574109A JP 2000574109 A JP2000574109 A JP 2000574109A JP 2002526499 A5 JP2002526499 A5 JP 2002526499A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000574109A
Other languages
Japanese (ja)
Other versions
JP2002526499A (ja
JP4145492B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP1999/006899 external-priority patent/WO2000017200A1/en
Publication of JP2002526499A publication Critical patent/JP2002526499A/ja
Publication of JP2002526499A5 publication Critical patent/JP2002526499A5/ja
Application granted granted Critical
Publication of JP4145492B2 publication Critical patent/JP4145492B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000574109A 1998-09-23 1999-09-17 テトラヒドロピリドエーテル Expired - Lifetime JP4145492B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19843504 1998-09-23
EP19843504.5 1998-09-23
EP98117988 1998-09-23
EP98117988.0 1998-09-23
PCT/EP1999/006899 WO2000017200A1 (en) 1998-09-23 1999-09-17 Tetrahydropyridoethers

Publications (3)

Publication Number Publication Date
JP2002526499A JP2002526499A (ja) 2002-08-20
JP2002526499A5 true JP2002526499A5 (cg-RX-API-DMAC7.html) 2005-11-17
JP4145492B2 JP4145492B2 (ja) 2008-09-03

Family

ID=26049024

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000574109A Expired - Lifetime JP4145492B2 (ja) 1998-09-23 1999-09-17 テトラヒドロピリドエーテル

Country Status (31)

Country Link
US (4) US6436953B1 (cg-RX-API-DMAC7.html)
EP (1) EP1115725B1 (cg-RX-API-DMAC7.html)
JP (1) JP4145492B2 (cg-RX-API-DMAC7.html)
KR (1) KR100668400B1 (cg-RX-API-DMAC7.html)
CN (2) CN1155598C (cg-RX-API-DMAC7.html)
AT (1) ATE231862T1 (cg-RX-API-DMAC7.html)
AU (1) AU763463B2 (cg-RX-API-DMAC7.html)
BG (1) BG65195B1 (cg-RX-API-DMAC7.html)
BR (1) BR9914044A (cg-RX-API-DMAC7.html)
CA (1) CA2344251A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ292335B6 (cg-RX-API-DMAC7.html)
DE (1) DE69905178T2 (cg-RX-API-DMAC7.html)
DK (1) DK1115725T3 (cg-RX-API-DMAC7.html)
EA (1) EA005377B1 (cg-RX-API-DMAC7.html)
EE (1) EE04677B1 (cg-RX-API-DMAC7.html)
ES (1) ES2191464T3 (cg-RX-API-DMAC7.html)
GE (1) GEP20032926B (cg-RX-API-DMAC7.html)
HK (1) HK1038360B (cg-RX-API-DMAC7.html)
HR (1) HRP20010224A2 (cg-RX-API-DMAC7.html)
HU (1) HUP0102990A3 (cg-RX-API-DMAC7.html)
ID (1) ID28896A (cg-RX-API-DMAC7.html)
IL (2) IL142063A0 (cg-RX-API-DMAC7.html)
NO (1) NO317304B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ510610A (cg-RX-API-DMAC7.html)
PL (1) PL193616B1 (cg-RX-API-DMAC7.html)
PT (1) PT1115725E (cg-RX-API-DMAC7.html)
RS (1) RS50145B (cg-RX-API-DMAC7.html)
SI (1) SI1115725T1 (cg-RX-API-DMAC7.html)
SK (1) SK285165B6 (cg-RX-API-DMAC7.html)
TR (1) TR200100805T2 (cg-RX-API-DMAC7.html)
WO (1) WO2000017200A1 (cg-RX-API-DMAC7.html)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ292335B6 (cs) 1998-09-23 2003-09-17 Altana Pharma Ag Tetrahydropyridoethery, jejich použití a farmaceutický prostředek
US6503923B1 (en) 1999-04-17 2003-01-07 Altana Pharma Ag Haloalkoxy imidazonaphthyridines
CA2285516C (en) * 1999-05-12 2010-12-07 President And Fellows Of Harvard College Dopamine transporter imaging agents
MXPA02009549A (es) * 2000-03-29 2004-05-14 Altana Pharma Ag Imidazopiridinas triciclicas.
ATE311389T1 (de) * 2000-03-29 2005-12-15 Altana Pharma Ag Wirkstoffvorläufer von imidazopyridin-derivaten
CN1692113A (zh) * 2000-10-25 2005-11-02 奥坦纳医药公司 作为胃分泌抑制剂的多取代咪唑并吡啶
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
WO2002069968A1 (en) * 2001-03-08 2002-09-12 Astrazeneca Ab New use
EP1414821B1 (en) 2001-08-02 2006-08-16 ALTANA Pharma AG Tricyclic epoxides
CN1656096A (zh) * 2001-08-03 2005-08-17 奥坦纳医药公司 用于治疗胃肠病症的烷基-取代的咪唑吡啶
WO2003014120A1 (en) * 2001-08-03 2003-02-20 Altana Pharma Ag Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases
EP1476445A1 (en) 2002-02-15 2004-11-17 ALTANA Pharma AG Tricyclic n-acyl compounds
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
AU2003227710A1 (en) * 2002-05-07 2003-11-11 Altana Pharma Ag New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders
MXPA05005117A (es) 2002-11-19 2005-07-01 Altana Pharma Ag Imidazopiridinas 8-sustituidas.
US7879833B2 (en) 2002-12-12 2011-02-01 Nycomed Gmbh Combination medicament
KR20050088176A (ko) * 2002-12-20 2005-09-02 알타나 파마 아게 8-트리알킬실록시-2-메틸-9-페닐-7-옥소-7,8,9,10-테트라히드로이미다조[1,2-h][1,7]나프티리딘
EP1599175A2 (en) * 2003-02-17 2005-11-30 ALTANA Pharma AG Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders
MXPA04008070A (es) 2003-03-10 2004-11-26 Altana Pharma Ag Novedoso proceso para la preparacion de roflumilasto.
TW200503783A (en) * 2003-04-11 2005-02-01 Altana Pharma Ag Oral pharmaceutical preparation for proton pump antagonists
SA04250092B1 (ar) * 2003-05-14 2008-05-04 التانا فاروا ايه جي مركب وسيط جديد لتحضير مركبات إيميدازوبيريدين imidazopyridines فعالة علاجياً
WO2004105795A1 (en) * 2003-05-27 2004-12-09 Altana Pharma Ag Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility
AU2004268641A1 (en) * 2003-08-29 2005-03-10 Dynogen Pharmaceuticals, Inc. Compositions useful for treating gastrointestinal motility disorders
ES2452691T5 (es) 2003-09-16 2022-09-14 Covis Pharma Gmbh Uso de ciclesonida para el tratamiento de enfermedades respiratorias
EP1974730A1 (en) 2003-11-03 2008-10-01 AstraZeneca AB Imidazo[1,2-a]pyridine derivatives for use in the treatment of sleep disturbance due to silent gastro-esophageal reflux
AU2004298453A1 (en) 2003-12-19 2005-06-30 Altana Pharma Ag Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
NZ549011A (en) * 2004-02-17 2009-04-30 Altana Pharma Ag Tricyclic imidazopyridines and intermediates for the synthesis thereof
PL1784404T3 (pl) 2004-09-03 2012-04-30 Yuhan Corp Pochodne pirolo[2,3-c]pirydyny i sposoby ich wytwarzania
EP1784403B1 (en) 2004-09-03 2013-07-17 Yuhan Corporation Pyrrolo[3,2-b]pyridine derivatives and processes for the preparation thereof
US8148529B2 (en) 2004-09-03 2012-04-03 Yuhan Corporation Pyrrolo[3,2-C] pyridine derivatives and processes for the preparation thereof
JP5383183B2 (ja) * 2005-03-16 2014-01-08 タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツング ロフルミラストを含有する矯味された剤形
EP2080513A1 (en) 2008-01-16 2009-07-22 Schraermeyer, Ulrich, Prof. Dr. rer. nat Tetrahydropyridoethers for treatment of AMD
WO2011004882A1 (ja) * 2009-07-09 2011-01-13 ラクオリア創薬株式会社 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤
WO2012027240A1 (en) * 2010-08-23 2012-03-01 Schering Corporation Fused tricyclic inhibitors of mammalian target of rapamycin
KR101699145B1 (ko) * 2012-06-15 2017-02-03 (주)바이오팜솔루션즈 페닐알킬설파메이트 화합물 및 이를 포함하는 근육 이완제 조성물
EP3054949A1 (en) 2013-10-08 2016-08-17 Katairo GmbH Tetrahydropyridoethers for the treatment of stargardt's disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) * 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
DE3855692D1 (de) 1987-07-16 1997-01-16 Byk Gulden Lomberg Chem Fab Imidazo[1,2-a]pyridine
SE9401197D0 (sv) * 1994-04-11 1994-04-11 Astra Ab Active compounds
AU702166B2 (en) * 1994-07-28 1999-02-18 Byk Gulden Lomberg Chemische Fabrik Gmbh Acylimidazopyridines
WO1998042707A1 (en) * 1997-03-24 1998-10-01 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahydropyrido compounds
CU23088A3 (es) * 1997-03-24 2005-10-19 Altana Pharma Ag Compuestos de tetra-hidropiridina.
CZ292335B6 (cs) 1998-09-23 2003-09-17 Altana Pharma Ag Tetrahydropyridoethery, jejich použití a farmaceutický prostředek

Similar Documents

Publication Publication Date Title
BE2018C020I2 (cg-RX-API-DMAC7.html)
BE2015C057I2 (cg-RX-API-DMAC7.html)
BE2016C007I2 (cg-RX-API-DMAC7.html)
BE2015C018I2 (cg-RX-API-DMAC7.html)
BE2013C001I2 (cg-RX-API-DMAC7.html)
JP2002525694A5 (cg-RX-API-DMAC7.html)
BE2008C046I2 (cg-RX-API-DMAC7.html)
BE1025464I2 (cg-RX-API-DMAC7.html)
BE2010C011I2 (cg-RX-API-DMAC7.html)
BRPI0017527B8 (cg-RX-API-DMAC7.html)
JP2002500922A5 (cg-RX-API-DMAC7.html)
JP2002518111A5 (cg-RX-API-DMAC7.html)
BE2008C047I2 (cg-RX-API-DMAC7.html)
BE2011C004I2 (cg-RX-API-DMAC7.html)
BRPI0001672A2 (cg-RX-API-DMAC7.html)
JP2002507572A5 (cg-RX-API-DMAC7.html)
BRPI0001542A2 (cg-RX-API-DMAC7.html)
JP2002526499A5 (cg-RX-API-DMAC7.html)
BRPI0012675B8 (cg-RX-API-DMAC7.html)
BRPI0017522A2 (cg-RX-API-DMAC7.html)
BRPI9917761A2 (cg-RX-API-DMAC7.html)
BRMU7902607U2 (cg-RX-API-DMAC7.html)
IN191700B (cg-RX-API-DMAC7.html)
AU2000262176A8 (cg-RX-API-DMAC7.html)
CN3099013S (cg-RX-API-DMAC7.html)